The global medical device technology market is expected to grow by nearly 5% in the next four years, with additive manufacturing (AM) playing an increasingly important role — enabling the production of parts ranging from diagnostic equipment components and surgical tools to elements for life-changing orthoses and implants. It’s also a manufacturing process that must, like any other for this sector, employ specific safeguards and processes to guarantee the consistent quality of parts produced.

The POLYLINE project achieved to be the first successful implementation of an automated additive manufacturing production line for polymer parts at scale. At the Additive Manufacturing Campus of BMW, the project partners made real 3D printing serial production with high throughput a reality. It is therefore not surprising that after the defined three years’ project time, BMW, DyeMansion, EOS and Grenzebach – four partners of the consortium – draw a very positive balance.

As a leading manufacturer of advanced adhesive solutions for the medical industry, Henkel has launched a novel medical grade light cure adhesive designed for devices that are to be worn on the body. The new product is formulated without IBOA (Isobornyl Acrylate) or any other known skin sensitizing monomers. The adhesive is also formulated to conform to EU MDR 2017 regulations concerning use of CMR (carcinogenic, mutagenic, or toxic for reproduction) substances in medical devices making it a robust option for new designs.

AMGTA Lifecyle Research report highlights Stratasys’s work with the Dyloan Bond Factory, a Pattern Group Company in the comparison of additive manufacturing vs. traditional production processes

Evidence revealed that a Stratasys PolyJet™ material jetting approach can cut CO2e emissions by 24.8% in comparison to injection molding and save 48% of stock material across the supply chain

Meet Our Sponsors

Latest Sponsor News

Articles Most Read

Latest News


Articles View Hits

Who's Online

We have 127 guests and no members online